004310.KS
Hyundai Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,680.00
+1.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 47.16x
- PEG TTM
- 12.86x
- Price / book
- 1.57x
- Price / sales
- 0.99x
- Price / cash flow
- 62.62x
Enterprise value
- Enterprise value
- KRW 232.5B
- EV / sales
- 1.15x
- EV / EBITDA
- 20.32x
- EV / EBIT
- 38.31x
- Market cap
- KRW 201.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026